Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD by Andrianopoulos, Vasileios et al.
Andrianopoulos et al. BMC Pulmonary Medicine 2014, 14:97
http://www.biomedcentral.com/1471-2466/14/97RESEARCH ARTICLE Open AccessCharacteristics and determinants of endurance
cycle ergometry and six-minute walk distance in
patients with COPD
Vasileios Andrianopoulos1*, Scott S Wagers2, Miriam TJ Groenen1, Lowie E Vanfleteren1, Frits ME Franssen1,
Frank WJM Smeenk3, Ioannis Vogiatzis4,5, Emiel F M Wouters1,6, Martijn A Spruit1 and On behalf of the CIRO+
Rehabilitation NetworkAbstract
Background: Exercise tolerance can be assessed by the cycle endurance test (CET) and six-minute walk test (6MWT) in
patients with Chronic Obstructive Pulmonary Disease (COPD). We sought to investigate the characteristics of functional
exercise performance and determinants of the CET and 6MWT in a large clinical cohort of COPD patients.
Methods: A dataset of 2053 COPD patients (43% female, age: 66.9 ± 9.5 years, FEV1% predicted: 48.2 ± 23.2) was
analyzed retrospectively. Patients underwent, amongst others, respiratory function evaluation; medical tests and
questionnaires, one maximal incremental cycle test where peak work rate was determined and two functional exercise
tests: a CET at 75% of peak work rate and 6MWT. A stepwise multiple linear regression was used to assess determinants.
Results: On average, patients had impaired exercise tolerance (peak work rate: 56 ± 27% predicted, 6MWT: 69 ± 17%
predicted). A total of 2002 patients had CET time of duration (CET-Tend) less than 20 min while only 51 (2.5%) of the
patients achieved 20 min of CET-Tend . In former patients, the percent of predicted peak work rate achieved differed
significantly between men (48 ± 21% predicted) and women (67 ± 31% predicted). In contrast, CET-Tend was longer in
men (286 ± 174 s vs 250 ± 153 s, p < 0.001). Also, six minute walking distance (6MWD) was higher in men compared to
women, both in absolute terms as in percent of predicted (443 m, 67%predicted vs 431 m, 72%predicted, p < 0.05).
Gender was associated with the CET-Tend but BMI, FEV1 and FRC were related to the 6MWD highlighting the different
determinants of exercise performance between CET and 6MWT.
Conclusions: CET-Tend is a valuable outcome of CET as it is related to multiple clinical aspects of disease severity in
COPD. Gender difference should temper the interpretation of CET.
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Constant work rate cycle ergometry, the so-called cycle
endurance test (CET), has been put forth as an import-
ant assessment of exercise tolerance for patients with
chronic obstructive pulmonary disease (COPD) [1-3]. CET
endurance time (CET-Tend) can be used in the evaluation
of exercise tolerance [4]. Yet our understanding of CET lags
behind that of the commonly used six minute walk test
(6MWT) [5-8]. In fact, the first report of minimal clinically* Correspondence: vasilisandrianopoulos@ciro-horn.nl
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article, unless otherwise stated.important difference for the CET has only been published
in 2008 [9].
Neder and colleagues [10], in a detailed study aimed at
plotting power duration relationship from a series CETs,
found that the average critical power asymptote (i.e.: the
power at which an individual can cycle for 20 minutes)
in patients with COPD was 81% of the peak work rate
achieved on a maximal incremental test. Anecdotal clin-
ical experience, however, suggests that few patients with
COPD can cycle that long, even at 75% of peak work
rate, that is the level at which most CETs are performed
[11]. CET performed at this fixed proportion of peak
incremental workload capacity does not cause identicalCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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20 minutes is considered as the maximal allowable
CET-Tend for a CET [13], and the test is usually
stopped at that point.
Constant work rate endurance protocols in CET are
based on the maintenance of exercise effort until the
exhaustion [14]. Although CET is considered as sub-
maximal exercise, it is aimed to assess the maximal
aerobic capacity of patients and it is suggested as a
highly repeatable test across run-in visits [15]. However,
the utility of CETs at 75% peak work rate comes into
doubt as more patients would cycle to the obligatory
stopping point of 20 minutes [10]. Similarly, the 6MWT
even though self-paced, it can be considered as a maximal
sustainable exercise in patients with COPD [16]. Both
testing modalities for assessing exercise tolerance may
provoke different physiological responses and cause dif-
ferent levels of dyspnea and fatigue during the exertion
to patients with COPD [17,18]. Furthermore, the sex of
patients has been related to dyspnea in the 6MWT [19]
and may also determine the exertion during the CET.
From a physiological point of view, CET and 6MWT may
not be interchangeable exercise tests and the determinants
of exercise performance between the tests can differ.
Herein, we report a retrospective analysis of CET-Tend
in a large clinical cohort of patients with COPD under-
going initial evaluation for pulmonary rehabilitation (PR)
[20]. We sought to compare the results of CETs in a large
clinical cohort to those of a 6MWT and we sought to
determine how often a clinical cohort of patients with
COPD achieved a maximal CET-Tend of 20 minutes
during a CET performed at a predetermined 75% of peak




We extracted data from the records of 2991 patients
with the diagnosis of COPD who were evaluated during
the initial assessment of a comprehensive pulmonary
rehabilitation program at CIRO+, center of expertise
for chronic organ failure in Horn (The Netherlands)
between January 1, 2005 and July 1, 2013 [20]. Of these
records, 2053 patients met the following inclusion criteria:
all necessary data present, a primary diagnosis of COPD, a
FEV1/FVC ratio of ≤0.70, evidence that they had reached a
physiological maximum during the incremental maximal
cardiopulmonary exercise test on a stationary cycle ergom-
eter (i.e., ventilation ≥85% of maximal voluntary ventilation;
heart rate ≥80% of the age-predicted heart rate; symptom
score for dyspnea ≥7/10 points; and/or symptoms score for
fatigue ≥7/10 points), CET done at 75% of peak work rate,
and not representing a repeat admission for the same
patient. Ethical approval was not indicated because allof the tests were done as part of the routine initial
assessment, and analyzed retrospectively. The Board of
Directors of CIRO + approved the use of de-identified
patients’ record.
Testing
As part of routine initial assessment, patients underwent,
amongst other tests and questionnaires, a maximal in-
cremental cycle test where peak work rate is determined.
Subsequently, on a different day, patients performed a
CET at 75% of the determined peak work rate. Patients
also performed two 6MWTs [21] while the test with the
longest distance was used for further analysis. All tests
were done according to ATS/ERS guidelines [1,8]. Rou-
tine post-bronchodilator spirometry, physical examination,
medical history, and Medical Research Council (MRC)
dyspnea scale were obtained. Using dual energy x-ray
absorptiometry (DEXA), the fat free mass index (FFMI)
for each individual was calculated.
Statistics
All analyses were carried out using SPSS 19, Graphpad
Prism 6 and Sigmaplot 12. Data are reported as means
with standard deviation (±SD). For parametric data, com-
parison between men and women were made using a two
tailed unpaired t-test, and for categorical data Pearson
Chi-Square tests were used, as appropriate. Frequency
distributions were used to determine performance quar-
tiles for the CET-Tend and six-minute walk distance
(6MWD) allowing for comparison of the clinical parame-
ters between quartiles. For all comparisons, patients
reaching CET-Tend of 20 minutes (51 patients, 2.5%)
were excluded from the dataset of 2053 patients as they
represented an artificial stopping point, and thereby
could artificially reduce standard error. After excluding
this group of patients, a dataset of 2002 patients was
analyzed for detecting significant differences. For para-
metric data quartiles were compared using one way
ANOVA and for non parametric data quartiles were
compared using Kruskal-Wallis test. All multiple compari-
sons were followed by Bonferonni correction. A stepwise
multiple linear regression was used to determine clinical
parameters that independently influenced test perform-
ance. The level of significance was set at p <0.05.
Results
Clinical parameters
On average, patients (n = 2002; CETend <20 min) had
moderate to very severe COPD, a normal BMI, normal
resting arterial oxygen and carbon dioxide tension, and
symptoms of dyspnea. Gender differences were noticed:
men were older, and had a significantly higher height,
weight, BMI, FFMI, and FEV1% predicted compared to
women. Then again, women had a significantly worse
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oxygen therapy (LTOT) (Table 1).
Maximal incremental cycle tests
On average, patients had a limited maximal exercise
tolerance. The percent of predicted peak work rate
achieved was significantly different between men
(48 ± 21% predicted) and women (67 ± 31% predicted;
p < 0.001; Table 2).
Endurance tests
Average CET-Tend was 271±166 s. This differed signifi-
cantly between men (286 s) and women (250 s; p < 0.001).
Average 6MWD was 438±113 m. The 6MWD was higher
in men (443 m) compared to women (431 m; p = 0.019).
Then again, 6MWD% predicted differed between men
(67 ± 17% predicted) and women (72 ± 15% predicted;
p < 0.001; Table 2).
Distribution of cycle endurance times and six minute
walking distances
When separated into 1 minute intervals, the frequency
distribution curve for CET-Tend shows a leftward kurtosis
in men and women (Figure 1A). Only 51, or 2.5%, of pa-
tients achieved CET-Tend of 20 minutes. When separated
into 50 meters intervals, the frequency distribution curve
for 6MWD shows a rightward kurtosis in men and women
(Figure 1B).Table 1 Demographics of COPD patients
Characteristics All patients (n = 2002)
Age, yrs 66.9 (9.5)
Weight, kg 71.9 (16.5)
Height, m 1.68 (0.9)
BMI, kg/m2 25.4 (5.2)
FFMI, kg/m2 17.0 (2.4)
FEV1, % predicted 48.2 (23.2)
FVC, % predicted 95.9 (22.3)
FEV1/FVC, r 39.8 (11.8)
FRC, % predicted 150.1 (35.9)
DLCO, % predicted 52.9 (18.1)
PO2, kPa 9.8 (2.3)
PCO2, kPa 5.3 (1.4)
MRC dyspnea grade 3.3 (1.1)
GOLD stage I 96 (4.8)
GOLD stage II 649 (32.4)
GOLD stage III 730 (36.5)
GOLD stage IV 527 (26.3)
Receiving LTOT, n, (%) 408 (20.4)
Average values are shown for exercise tests and clinical parameters. The values are
significant differences (p < 0.05).Associations
The CET-Tend and the 6MWD were significantly associ-
ated in the whole sample, as well as after stratification
for gender presenting a moderate positive correlation
(Figure 2).
Examination of performance quartiles
There is clear performance quartile gradation for FEV1%,
FVC%, CET-Tend, peak power output of absolute watt and
watt% predicted (sole exception 3rd/4th quartile in CET)
and the 6MWD with significant differences amongst all
quartiles for the exercise performance of CET and the
6MWT (Figure 3). Moreover, there is performance quar-
tile gradation for age with significant differences of age for
the 4th and the rest of quartiles for CET and amongst all
the quartiles for the 6MWT. Additionally, performance
quartile gradation significant differences were detected
across the GOLD stages between 1st and 4th, 1st and 3rd,
and 2nd and 4th in cycling and amongst all quartiles in
6MWT. The performance quartile gradation for the FRC
demonstrated significant differences in all quartiles for
CET while a similar pattern was observed for the 6MWT.
The performance quartile gradation for the DLCO dem-
onstrated significant differences amongst 1st and 3rd-4th,
2nd and 4th quartiles for the CET and 6MWT respectively.
Significant difference in BMI were observed only in CET
for 1st and 3rd-4th, 2nd and 3rd-4th, but only between 1st
and 4th in 6MWT. Similarly, FFMI performance quartileMales (n = 1134) (57%) Females (n = 868) (43%)
69.0 (9.1) 64.3 (9.2)*
77.2 (15.9) 65.0 (14.7)*
1.73 (0.7) 1.62 (0.6)*
25.8 (4.9) 25.0 (5.5)*
18.1 (2.2) 15.5 (1.8)*
47.2 (20.7) 49.6 (26.1)*
93.0 (21.7) 99.7 (22.7)*
38.9 (11.9) 40.9 (11.4)*
146.3 (37.5) 154.9 (33.0)*
55.3 (30.1) 50.9 (25.7)*
9.8 (2.2) 9.7 (2.4)
5.2 (1.2) 5.4 (1.5)
3.3 (1.1) 3.4 (1.0)
48 (4.2) 48 (5.5)
362 (31.9) 287 (33.1)
419 (36.9) 311 (35.8)
305 (26.9) 222 (25.6)
230 (20.3) 178 (20.5)
reported for the entire cohort and then for men and women. Asterisk denotes
Table 2 Parameters of exercise tests in patients with COPD
Parameters All patients (n = 2002) Males (n = 1134) (57%) Females (n = 868) (43%)
Maximal incremental cycle test
Work Rate peak, w 69 (30) 77 (33) 60 (23)**
Work Rate peak, % predicted 56 (27) 48 (21) 67 (31)**
VE, % Max Voluntary Ventilation 87 (24) 86 (23) 89 (25)
HR max, % age-predicted 81 (12) 80 (13) 81 (12)
Systolic BP post, mm Hg 176 (33) 176 (34) 176 (32)
Diastolic BP post, mm Hg 84 (15) 84 (15) 84 (14)
Dyspnea (Borg) post, points 7.2 (2.0) 7.1 (2.0) 7.2 (2.0)
Leg Fatigue (Borg) post, points 5.9 (2.6) 5.8 (2.5) 6.0 (2.6)
Cycle endurance test (CET)
Work Rate mean, w 52 (23) 58 (25) 45 (17)**
Endurance cycling time, s 271 (166) 286 (174) 250 (153)**
Dyspnea (Borg) post, points 5.3 (2.3) 5.4 (2.3) 5.1 (2.3)*
Leg Fatigue (Borg) post, points 5.7 (2.2) 5.8 (2.2) 5.6 (2.1)
Six-minute walk test (6MWT)
6MWD, m 438 (113) 443 (120) 431 (104)*
6MWD, % predicted 69.0 (16.5) 66.9 (17.1) 71.7 (15.3)**
Dyspnea (Borg) post, points 5.2 (4.4) 5.2 (4.2) 5.1 (4.7)
Leg Fatigue (Borg) post, points 4.4 (4.6) 4.4 (4.2) 4.4 (4.8)
Average values are shown for exercise tests and clinical parameters. The values are reported for the entire cohort and then for men and women. Asterisks
denotes significant differences (* p < 0.05; ** p < 0.001).
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significance was detected for the 6MWT (Figure 3). When
performance quartiles were determined separately for men
and women, men demonstrated more evident differences
in FFMI quartiles compared to women. That fact indicates
that FFMI may determine the exercise performance more
in men than women with COPD (Please see online
supplement for details, Additional file 1: Tables S1–S2;
Additional file 2: Figures S1 & Additional file 3: Figure S2).
Stepwise multiple linear regression
Reverse stepwise linear regression revealed that age,
gender, FFMI, DLCO%, GOLD stage, Dyspnea and leg
fatigue Borg scores at rest independently influence
CET-Tend (Table 3). Age, BMI, FFMI, FEV1%, FVC/
FEV1, GOLD stage, FRC, DLCO, and leg fatigue Borg
score at rest were retained in the model when 6MWD
was the dependent variable (Table 4). The model for
CET was able to account for only 15.1% of the variabil-
ity in cycle endurance time, while that for 6MWT
accounted for 34.0% of the variability in 6MWD.
Discussion
In current study, we aimed to investigate the characteristics
of functional exercise performance and the determinants
which can influence the exercise performance in CET
and the 6MWT in a large cohort of patients withmoderate to severe COPD (Table 1). The main finding of
this study is that CET-Tend can be determined by different
physiological and clinical characteristics in comparison
with the 6MWT. Of particular clinical importance, the
sex of patients influenced CET-Tend but not in the
6MWD (Tables 2–4). Moreover, 6MWD seems to be
more determined by lung function compared to CET-
Tend (Tables 3–4). Also, a number of independent
physiological and clinical characteristics demonstrated
a different pattern in performance quartile gradation
between CET and 6MWT (Figure 3).
Gender appears to be a strong determinant of CET-Tend
in contrast to 6MWD. We found that men on average
achieved a higher peak work rate and cycled longer during
the CET than women; in spite of the fact the men were
older with more impaired lung function (Tables 1 and 2).
Previous studies have demonstrated that quadriceps
muscle strength [22] and peak VO2 [23,24] have small
reductions in COPD patients over a 1 to 5 year period.
Moreover, quadriceps muscle strength is positively related
to DLCO in patients with COPD [25] and the studied
male population had a greater diffusing capacity which
could be accountable for the better cycle performance.
When we examined the performance quartiles, there was
not as much of a gradation in gender proportion except
the 4th quartile among the 6MWD performance quartiles
compared to that seen in the CET-Tend of performance
Figure 1 Frequency distribution of CET-Tend and 6MWD in patients with COPD. (A) Frequency distribution of 75% of peak work rate CET-Tend.
The number of individuals for each bin of duration time is represented by the height of each column (y-axis). Each bin represents 1 minute (x-axis). Only
51 (2.5%) of the 2053 patients who met the inclusion criteria reached the 20 minute maximal duration. (B) frequency distribution of six minute walking
distance (6MWD). The number of individuals for each bin of walking meters is represented by the height of each column (y-axis). Each bin represents
1 minute (x-axis).
Figure 2 Pearson’s correlations between CET-Tend and 6MWD. A positive moderate correlation was detected in all models between the
CET-Tend and 6MWD for all patients and stratified by gender.
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Figure 3 Performance quartile comparisons. Using the frequency distribution patients were separated into performance quartiles. With the
quartiles increasing left to right (CET: quartiles with wave hashing, 6MWT: quartiles with diagonal hashing). Comparisons were then made between the
quartiles of CET and between quartiles of 6MWT for all variables. Significant differences are demonstrated by lines above the relevant bars. Dashed line
on gender graph represents the point where is an equal number of men and women.
Table 4 Stepwise linear regression model of Six minute
walking distance in meters
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between all the CET performance quartiles in FFMI, which
was not seen in the 6MWD performance quartiles. How-
ever, as would be expected, FFMI was on average lower
in the female population compared to men (Table 1).
Thus, the question remains whether and to what extent
gender differences in CET reflected the lower FFMI in
women, or if the FFMI differences were simply a reflec-
tion of inherent gender differences. To examine this
question we stratified the data into performance quar-
tiles for each gender. We found that the difference in
FFMI between performance quartiles was no longer ap-
parent in women except for the 1st and 4th CET per-
formance quartiles (Additional file 3: Figures S2), but
still apparent in men between all the quartiles in CET
and the 1st and 4th, and the 1st and 3rd quartiles in the
6MWT. There was also less of a CET quartile gradation
in FVC% and GOLD stage compared to that seen in
6MWD. To further elucidate the importance of gender
and FFMI as determinants of test performance we car-
ried out stepwise multiple regressions. The parameters
that were retained when CET-Tend was used as the
dependent variable were age, gender, FFMI, DLCO%,
GOLD stage, Dyspnea and leg fatigue Borg scores at rest
(Table 3). When 6MWD was used as the dependent vari-
able, age, BMI, FFMI, FEV1%, FEV1/FVC, FRC%, DLCO%,
GOLD stage and leg fatigue Borg score at rest were
retained, but gender was not retained (Table 4). Perform-
ing a stepwise multiple regression after stratification by
gender, FFMI was not retained in women but it was
retained in men for the CET-Tend (Additional file 1:Table 3 Stepwise linear regression model of endurance




t value p value
Age, yrs −3.35 0.57 −5.84 <0.001
Sex, m/f −31.51 12.91 −2.44 0.015
FFMI, kg/m2 8.49 2.79 3.04 0.002
GOLD stage −42.09 6.59 −6.39 <0.001
DLCO, % 1.21 0.32 3.83 <0.001
Dyspnea before test, index −13.38 4.43 −3.02 0.003
Leg fatigue before
test, index
−6.96 3.52 −1.98 0.048
Multiple linear regression model for parameters predictive of endurance cycle time
Using isolated linear regression determination a stepwise multiple linear
regression model was established with an r2 of 15.1%.Tables S1-S2). Apparently quartile difference in FFMI
(Figure 3) can be likely a reflection of an inherent gen-
der differences beyond fat free mass. On Thus, it can be
concluded that gender is an important determinant of
CET-Tend. Interestingly, peak aerobic capacity of pa-
tients with COPD was not determined by gender, after
correction for isokinetic quadriceps peak torque,
DLCO, FEV1, BMI, age and lower-limb lean muscle
mass [26].
The model for 6MWD was much better at explaining
variability in test performance (r2 of 34.0%) compared to
that for CET (r2 of 15.1%). Other authors have also found
it difficult to build a model that is highly predictive of
CET performance [12,27]. This perhaps explains why we
do not have a predictive equation for CET-Tend yet. It does
however suggest that there are determinants of CET
which we do not understand. This may reflect the com-
plex nature of exercise intolerance in COPD.
CET-Tend seems to be influenced in a high extent from
the degree of disease severity classified by GOLD stages
more than the inter-individual variation of FEV1 or other
specific clinical characteristics compared to 6MWT. It
is observed that patients across the GOLD stages are
characterized by increased physical deconditioning which
leads to a progressive deterioration in lower limb muscle
function [28]. The impact of the power/duration relation-
ship on the exercise tolerance indicates that endurance is
influenced by the intensity of exercise [29]. Both exercise
tests are submaximal, however, the 6MWT is a self-pacedr2: 34.0%
Variable Coefficient Standard error t value p value
Age, yrs −3.97 0.29 −13.98 <0.001
BMI, kg/m2 −7.48 0.75 −9.87 <0.001
FFMI, kg/m2 8.77 1.59 5.52 <0.001
FEV1, % 1.28 0.29 4.44 <0.001
FEV1/FVC, r −1.60 0.42 −3.89 <0.001
GOLD stages −15.04 5.04 −3.02 0.003
FRC, % −0.43 0.11 −3.85 <0.001
DLCO, % 1.11 0.16 6.89 <0.001
Leg fatigue before
test, index
−15.80 1.64 −9.57 <0.001
Multiple linear regression model for parameters predictive of six minute walk
distance.
Using isolated linear regression determination a stepwise multiple linear
regression model was established with an r2 of 34.0%.
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termination of exercise in CET is more associated to the
inability to maintain the constant work load of exercise
and thus CET-Tend is associated to an overall impaired
health status, sex of patients and physical deconditioning
more than specific lung function characteristics compared
to the 6MWT.
In contrast to the findings of Neder and colleagues
[10], we found that the vast majority of patients with
COPD did not reach the 20 minute time point during a
CET at 75% of peak work rate. This discrepancy between
two studies is likely the result of differences in method-
ology and study populations. We retrospectively exam-
ined a clinical cohort of patients who were referred for
pulmonary rehabilitation, whereas Neder and colleagues
[10] studied a proscribed, smaller cohort with the intent
of defining the power duration asymptote. In the present
study, CET-Tend varied from 2 to 5 min for the most of
the patients (Figure 1A). This is similar to the findings of
Vivodtzev et al. [12] where most of the patients sustained
CET for of 3 to 5 minutes. Although the proportion of
patients with CET-Tend of 20 minutes was very small
(2.5%), we evaluated the possibility of an underestimation
in peak work rate that may result in unduly prolonged
CET. Nevertheless, peak heart rate, ventilation and dys-
pnea scores following a cardiopulmonary exercise test
indicated a maximum effort for those patients (Additional
file 1: Table S3). Moreover, a quartile gradation of ventila-
tion pattern derived by the maximum cardiopulmonary
exercise test (CPET) in cycle ergometer indicates the effort
to maintain O2 and CO2 homeostasis and may partly
provide an insight of the ventilatory profile in patients
of current study (Additional file 4: Figure S3).
Our findings showed a large variation in the CET-Tend
values (Figure 1A) which is also observed in the 6MWD,
though to a lesser extent (Figure 1B). Therefore, evalu-
ating patients with a CET at 75% of peak work rate
leaves room for demonstrating improvement with an
intervention, especially considering that the minimal
clinically important difference has been reported to be
between 100 and 200 seconds [9] or ~33% increased from
baseline [4]. Although the identical exercise intensity of
75% of peak work rate, the physiological stress may differ
amongst patients and thus the space for improvement
through PR exercise modalities can vary. Moreover, in
daily life the majority of patients have been adapted to
walking but not to cycling exercise and that may
results in a greater potential of improvement in CET
compared to 6MWT after PR. Nevertheless, O’Donnell
et al. [15] demonstrated that CET at 75% peak work rate
was highly repeatable across run-in visits: 7.9+/−4.8 and
8.4+/−5.1 min (R = 0.84) in 463 COPD patients indicating
the appropriateness of CET in the exercise assessment of
patients with COPD.There are methodological considerations to our study.
It is a retrospective cohort study which means there may
be unidentified confounders. We have no way of knowing
why some of the records were incomplete. Surely some
may be incomplete due to a failure of the patients to
complete the initial pulmonary rehabilitation assessment,
or refusal to perform a particular test. Some were also
repeat evaluations. Nonetheless the large sample size
helps to mitigate some of these potentially confounding
factors. Secondly, this is a population of patients who
have been referred for pulmonary rehabilitation which
could result in a referral bias towards patients with a
greater degree of limitation. Regardless, our findings
sufficiently demonstrate that performing CET at 75% of
peak work rate is a reasonable effort level for a population
of COPD patients being referred for pulmonary rehabilita-
tion. However, a fixed proportion of peak work rate exercise
does not provide identical physiological stress amongst
patients. Furthermore, this study increases our under-
standing of gender differences in exercise testing and
highlights the complex pathophysiology of exercise intoler-
ance in COPD. There have been a number of gender differ-
ences reported in COPD [27,30-36]. Most intriguingly, it
has previously been shown that women have higher symp-
tom scores on the St. George’s Respiratory Questionnaire
(SGRQ) compared to men [27]. It may therefore be that
compared to 6MWT, which simulates a more routine daily
activity, cycle ergometry evokes more symptoms in women
compared to men resulting in reduced CET-Tend for
women. This could be a reflection of the fact that most
patients with COPD, even in the Netherlands, do not
routinely ride a bicycle, and thereby cycling may evoke
more dyspnea because of its unfamiliarity. In lieu of
predictive equations, this gender difference in CET
should be taken into consideration and used to temper
the interpretation of CET. In summary, CET at 75% of
peak work rate appears to be a useful clinical exercise
tool in COPD. There is plenty of room to demonstrate
improvement with an intervention and it measures a
different aspect of exercise tolerance compared to
6MWT. The fact that the determinants of CET-Tend are
not reducible to a model built from a handful of clinical
parameters also speaks to the importance of CET-Tend as
an independent measurement before and after pulmonary
rehabilitation. Furthermore, CET reflects gender differ-
ences in COPD, an aspect of the disease that is gaining
increasing recognition.
Conclusion
CET and 6MWT are not interchangeable exercise tests.
CET-Tend is a valuable outcome of CET as it is related to
multiple clinical aspects of disease severity in COPD.
Gender difference should temper the interpretation of
CET. BMI, FEV1 and FRC influence the walking
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the fixed proportion of workload capacity does not
provide the same physiological stress among patients,
improvement in CET-Tend after pulmonary rehabilita-
tion can reflect a total improvement of clinical status in
patients with COPD.
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Additional file 2: Performance quartile comparisons of men.
Using the frequency distribution 1134 male patients were separated into
performance quartiles. With the quartiles increasing left to right (CET:
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Comparisons were then made between the quartiles of CET and
between quartiles of 6MWT for all variables. Significant differences are
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differences are demonstrated by lines above the relevant bars.
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